Loading...

Canopy Growth Corporation

CGC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.19
$-0.03(-2.46%)
U.S. Market opens in NaNh NaNm

Canopy Growth Corporation (CGC) Stock Overview

Explore Canopy Growth Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap532.2M
P/E Ratio-1.73
EPS (TTM)$-1.35
ROE-0.53%
Fundamental Analysis

AI Price Forecasts

1 Month$0.67
3 Months$3.08
1 Year Target$0.00

CGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Canopy Growth Corporation (CGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.73 and a market capitalization of 532.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.87%
5-Day Change
2.16%
1-Month Change
23.60%
3-Month Change
-0.42%
6-Month Change
-12.22%
Year-to-Date (YTD) Change
3.95%
1-Year Change
-20.47%
3-Year Change
-91.02%
5-Year Change
-99.57%
All-Time (Max) Change
-96.73%

Contact Information

https://www.canopygrowth.com
855 558 9333
1 Hershey Drive, Smiths Falls, ON, K7A 0A8

Company Facts

1,029 Employees
IPO DateApr 7, 2014
CountryCA
Actively Trading

Frequently Asked Questions